When diagnosing a horse with degenerative joint disease, your words mean more than you might realize. Most horse owners dread hearing this diagnosis, and they might feel overwhelmed by the news.
According to Sherry Johnson, DVM, MS, PhD, DACVSMR, senior partner at Equine Sports Medicine in Pilot Point, Texas/Scottsdale, Arizona, there are a few ways veterinarians can communicate with clients to help them feel better about their horse’s DJD diagnosis.
- Establish that the horse’s comfort is your primary concern.
- Keep explanations of the condition brief and simple, and quickly transition from diagnosis to action steps.
- Present physical therapy options as positive, proactive measures that are important to the horse’s recovery.
- Share the benefits of early intervention with a PSGAG like Adequan i.m.® and how it can support their horse’s joints and reverse the disease process.
- Emphasize a team approach to management so owners understand how coordination between veterinary care, training approaches, and farrier work creates comprehensive support for their horse.
“End on a positive note, by reinforcing that with proper management, many horses with DJD continue to enjoy active, comfortable lives for years,” said Johnson.
Adequan® i.m. polysulfated glycosaminoglycan (PSGAG) solution 100 mg/mL
INDICATIONS
Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan (PSGAG). Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information at adequan.com.
Related Reading
Stay in the know! Sign up for EquiManagement’s FREE weekly newsletters to get the latest equine research, disease alerts, and vet practice updates delivered straight to your inbox.
![[Aggregator] Downloaded image for imported item #18375](https://s3.amazonaws.com/wp-s3-equimanagement.com/wp-content/uploads/2025/09/30140031/EDCC-Unbranded-26-scaled-1-768x512.jpeg)
![[Aggregator] Downloaded image for imported item #18890](https://s3.amazonaws.com/wp-s3-equimanagement.com/wp-content/uploads/2025/11/17113845/EDCC-Unbranded-3-scaled-1-768x512.jpeg)
